
A study found blood-based genomic testing can be completed in 27 hours, giving patients with cancer faster treatment decisions.

A study found blood-based genomic testing can be completed in 27 hours, giving patients with cancer faster treatment decisions.

New NCCN guidelines highlight personalized combo treatments and new options to help patients with advanced kidney cancer live longer, better lives.

In the phase 3 ATHENA-MONO trial, 5-year data show Rubraca helped delay cancer worsening in advanced ovarian cancer vs placebo.

Study shows home-based IV chemotherapy at Mayo Clinic was safely delivered with close monitoring, reducing treatment burden for patients with cancer.

Patients with cancer are referred for psychosocial support to address emotional distress and mental health needs, according to a new study.

Dr. Marleen Meyers discusses improving survival rates, the evolving needs of younger cancer survivors and how caregivers can sustain long-term support.

A structured exercise program may reduce cognitive decline, often referred to as “chemo brain,” in patients receiving chemotherapy for the first time.